<DOC>
	<DOCNO>NCT01638143</DOCNO>
	<brief_summary>The primary objective study compare absorption vitamin K2 ( menaquinone-7 ) intake three different vitamin K2 supplement .</brief_summary>
	<brief_title>Bio-equivalence Study</brief_title>
	<detailed_description>Several manufacturer produce vitamin K2 raw material different form , namely oil powder . To ensure bioequivalence different vitamin K2 source , investigator interest compare bioavailability three different vitamin K2 formulation already commercially available . Two different oil one powder product compare randomized cross-over trial . The investigator hypothesize different vitamin K2 source give difference bioavailability vitamin K2 .</detailed_description>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<criteria>Healthy men woman , age 20 40 year Normal body weight height ( 18.5 kg/m2 &lt; BMI &lt; 30 kg/m2 ) Stable body weight ( weight gain loss &lt; 3 kg past 3 mo ) Written consent take part study Agreement adhere dietary restriction require protocol Abuse drug and/or alcohol Use vitamin supplement contain vitamin K Soy allergy Pregnancy history ) metabolic gastrointestinal disease include hepatic disorder Chronic degenerative and/or inflammatory disease , e.g . diabetes mellitus , renal failure Use oral anticoagulant Corticoid treatment Subjects anaemia subject recently donate blood plasma Systemic treatment topical treatment likely interfere coagulation metabolism ( salicylate , antibiotic )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>vitamin K2</keyword>
	<keyword>menaquinone-7</keyword>
	<keyword>bioavailability</keyword>
</DOC>